Preliminary thinking on the establishment of China's future pharmacovigilance systemZHANG Ya-juan, CHEN Hui, YANG Yue2017-2023
Updates and amendments of viral vaccines in the Chinese Pharmacopoeia 2020XU Li, GUO Zhong-ping2024-2028
Development and challenges of mRNA-based therapeuticsYU Ling-li, LI Xiang-yu, CHEN Gui-liang, HE Wu2029-2033
Research on the adaptive licensing pathway for new drug registration in EU and its enlightenment to ChinaWU Di, YANG Li, WEI Yan-yi, CHEN Yu-wen, WANG Zu-guang, YANG Ze-ying2034-2041
Analysis of technical opportunities in the field of traditional Chinese medicine antidepressants from the perspective of patentNIE Ze-wen, ZHANG Wen-feng, LI Qian, YUAN Hong-mei2042-2048
Consideration on the implementation of ICH M4QLIU Juan, ZHOU Li-ting, YU Hong, HE Wu, ZHANG Ning2053-2058
Considerations on clinical value of new traditional Chinese medicines from the view of TCM practiceAN Na, HAN Ling2059-2063
Advances in the methods of evaluating male reproductive toxicity in vitroLI Ying-qi, LI Shen-ning, ZHU Hai-mei, XU Han-lin, LI Man-qi, YANG Zi-xuan, QIU Yun-liang, CHANG Yan2064-2068
Research progress in application of multi-criteria decision analysis in the field of drug benefit-risk assessmentHUANG Qian-qian, WANG Tao, KANG Qi, CHEN Yang, QU Li-ping, ZOU Wen-jun2069-2074